Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Sanofi Pasteur Starts a Phase 2 Vaccine Trial

November 30, 2010 7:19 am | News | Comments

Sanofi Pasteur has started a Phase 2 clinical study of a vaccine for primary prevention of Clostridium difficile infection. The trial starting in the United States is focused on evaluating prevention of the first episode of CDI in at-risk individuals.


Trial Evaluates IMGN901 for Small-Cell Lung Cancer

November 30, 2010 7:14 am | News | Comments

ImmunoGen, Inc. announced the initiation of a randomized Phase 1/2 clinical trial to evaluate its proprietary product candidate, IMGN901, for first-line treatment of small-cell lung cancer (SCLC) in patients with extensive disease.


Public Health in the Genomic Era: A Global Issue

November 30, 2010 7:11 am | News | Comments

The major challenge for public health in the era of genomics is to generate the base of evidence necessary to demonstrate when use of genomic information in public health can improve health outcomes in a safe, effective and cost-effective manner.


Imaging Technique Finds Cancer Cells Fast

November 30, 2010 7:08 am | News | Comments

The long, anxious wait for biopsy results could soon be over, thanks to a tissue-imaging technique developed at the University of Illinois.


Role of Plasma Cells in Immune System Redefined

November 30, 2010 7:00 am | News | Comments

A team of scientists from The Scripps Research Institute have uncovered a previously unknown regulatory mechanism in the body’s response to eliminate pathogens, such as bacteria and viruses.


Survey Shows Complicated FDA/Industry Relationship

November 30, 2010 6:59 am | News | Comments

Growing public demand for increased medical device and drug safety, as well as the need to develop medical products faster, is complicating the current regulatory approval process and relationship between the life sciences industry and its chief regulator.


Merck Board Elects New CEO

November 30, 2010 6:56 am | News | Comments

Merck announced that its Board of Directors has elected Kenneth C. Frazier, currently Merck's president, as chief executive officer (CEO) and president, as well as a member of the board, effective January 1, 2011.


Game Drives Genetic Research

November 30, 2010 6:54 am | News | Comments

Playing online can mean more than killing time, thanks to a new game developed by a team of bioinformaticians at McGill University. Now, players can contribute in a fun way to genetic research.


FDA Approves Movement Disorder Drug

November 30, 2010 6:51 am | News | Comments

CNS Therapeutics announced the FDA approval of Gablofen for use in the management of severe spasticity, giving healthcare providers a new, easy-to-administer and cost-effective intrathecal baclofen treatment option.


LED Imaging Lights

November 29, 2010 6:45 am | Product Releases | Comments

Syngene has introduced its new plug and play LED lighting modules, which fit all new G:BOX and Dyversity imagers. These modules make it easy and cost-effective to enable these imagers to detect single or multiple fluorescent DNA and proteins.


Epigenetic Assay Kit

November 29, 2010 6:42 am | Drug Discovery & Development | Product Releases | Comments

PerkinElmer, Inc. launched a panel of epigenetics-based detection reagents to enable high-throughput screening for new drug candidates. The assay kits can screen for epigenetic factors to assist researching diseases such as neurodegeneration and cancer.


Warwick Analytical Adds CHN Analysis

November 29, 2010 6:34 am | News | Comments

Warwick Analytical Service has developed a fast and precise analytical service for organisations seeking to check the purity of their samples. Warwick Analytical Service is able to investigate and precisely measure the carbon, hydrogen, and nitrogen content of samples.


Plasticell Signs Collaboration with Sigma-Aldrich

November 29, 2010 6:30 am | News | Comments

Sigma-Aldrich will use its CompoZr Zinc Finger Nuclease Technology to engineer various human stem cell lines that enable tracking of differentiation to specific mature cell types via fluorescent reporters, integrated directly into developmentally expressed genes.


Breast Cancer Eludes Cellular Control Mechanisms

November 29, 2010 6:24 am | News | Comments

About 30% of breast cancer patients have tumors that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes.


US Urged to Stockpile Cholera Vaccine

November 29, 2010 6:19 am | News | Comments

In the wake of devastating cholera outbreaks in refugee camps in earthquake-wracked Haiti, a group of leading experts have urged the United States to create an emergency stockpile of cholera vaccines for future humanitarian use.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.